Cargando…
Metabolic Dysfunction in Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is an autosomal recessive genetic disorder leading to paralysis, muscle atrophy, and death. Significant advances in antisense oligonucleotide treatment and gene therapy have made it possible for SMA patients to benefit from improvements in many aspects of the once devas...
Autores principales: | Deguise, Marc-Olivier, Chehade, Lucia, Kothary, Rashmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198411/ https://www.ncbi.nlm.nih.gov/pubmed/34072857 http://dx.doi.org/10.3390/ijms22115913 |
Ejemplares similares
-
Low fat diets increase survival of a mouse model of spinal muscular atrophy
por: Deguise, Marc‐Olivier, et al.
Publicado: (2019) -
Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2016) -
Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice
por: Deguise, Marc-Olivier, et al.
Publicado: (2017) -
Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2020) -
Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy
por: Boyer, Justin G., et al.
Publicado: (2014)